HistCite - Chimerism and Transplantation topic search

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
2008
7201	7201 Bethge WA, Faul C, Bornhauster M, Stuhler G, Beelen DW, et al. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: An update BLOOD CELLS MOLECULES AND DISEASES. 2008 JAN-FEB; 40 (1): 13-19	4	34	12	35
7202	7202 Lang P, Mueller I, Greil J, Bader P, Schumm M, et al. Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients BLOOD CELLS MOLECULES AND DISEASES. 2008 JAN-FEB; 40 (1): 33-39	2	16	10	28
7203	7203 Strober S Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation BLOOD CELLS MOLECULES AND DISEASES. 2008 JAN-FEB; 40 (1): 48-54	4	8	9	24
7204	7204 van Rood J, Oudshoorn M Eleven million donors in Bone Marrow Donors Worldwide! Time for reassessment? BONE MARROW TRANSPLANTATION. 2008 JAN; 41 (1): 1-9	0	20	3	36
7205	7205 Bhatia M, Walters MC Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future BONE MARROW TRANSPLANTATION. 2008 JAN; 41 (2): 109-117	2	32	12	57
7206	7206 Grinnemo KH, Sylven C, Hovatta O, Dellgren G, Corbascio M Immunogenicity of human embryonic stem cells CELL AND TISSUE RESEARCH. 2008 JAN; 331 (1): 67-78	1	24	9	83
7207	7207 Chen DP, Tsai SH, Tseng CP, Wu TL, Chang PY, et al. Bone marrow transplant relapse with loss of an allele CLINICA CHIMICA ACTA. 2008 JAN; 387 (1-2): 161-164	2	3	7	10
7208	7208 Gleicher N Missed immunological opportunities in pregnancy EXPERT REVIEW OF CLINICAL IMMUNOLOGY. 2008 JAN; 4 (1): 1-3	0	2	2	19
7209	7209 Bohne F, Chmielewski M, Ebert G, Wiegmann K, Kurschner T, et al. T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes GASTROENTEROLOGY. 2008 JAN; 134 (1): 239-247	2	13	6	29
7210	7210 Mints M, Jansson M, Sadeghi B, Westgren M, Uzunel M, et al. Endometrial endothelial cells are derived from donor stem cells in a bone marrow transplant recipient HUMAN REPRODUCTION. 2008 JAN; 23 (1): 139-143	4	25	4	21
#	Date / Author / Journal	LCS	GCS	LCR	CR
7211	7211 Hasegawa D, Fukushima M, Hosokawa Y, Takeda H, Kawasaki K, et al. Successful treatment of chronic granulomatous disease with fludarabine-based reduced-intensity conditioning and unrelated bone marrow transplantation INTERNATIONAL JOURNAL OF HEMATOLOGY. 2008 JAN; 87 (1): 88-90	0	2	4	10
7212	7212 Boban I, Barisic-Dujmovic T, Clark SH Parabiosis and transplantation models show no evidence of circulating dermal fibroblast progenitors in bleomycin-induced skin fibrosis JOURNAL OF CELLULAR PHYSIOLOGY. 2008 JAN; 214 (1): 230-237	1	9	3	30
7213	7213 Birnbaum F, Jehle T, Schwartzkopff J, Sokolovska Y, Bohringer D, et al. Basiliximab following penetrating risk-keratoplasty - A prospective randomized pilot study KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE. 2008 JAN; 225 (1): 62-65	0	5	3	22
7214	7214 Joffre O, Santolaria T, Calise D, Al Saati T, Hudrisier D, et al. Prevention of acute and chronic allograft rejection with CD4(+)CD25(+)Foxp3(+) regulatory T lymphocytes NATURE MEDICINE. 2008 JAN; 14 (1): 88-92	18	142	8	30
7215	7215 Siebolts U, Thiele J, Zander T, Ditschkowski M, Beelen DW, et al. Differences in proportion and dynamics of recipient hematopoiesis following hematopoietic cell transplantation in CML and IMF ONCOLOGY REPORTS. 2008 JAN; 19 (1): 287-292	1	1	24	38
7216	7216 Reinhard H, Klingebiel T, Lang P, Bader P, Niethammer D, et al. Stem cell transplantation for polycythemia vera PEDIATRIC BLOOD & CANCER. 2008 JAN; 50 (1): 124-126	0	3	2	15
7217	7217 Koch U, Wilson A, Cobas M, Kemler R, MacDonald HR, et al. Simultaneous loss of beta- and gamma-catenin does not perturb hematopoiesis or lymphopoiesis BLOOD. 2008 JAN 1; 111 (1): 160-164	0	78	0	20
7218	7218 Ozsahin H, Cavazzana-Calvo M, Notarangelo LD, Schulz A, Thrasher AJ, et al. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation BLOOD. 2008 JAN 1; 111 (1): 439-445	8	50	2	43
7219	7219 Schuurman HJ, Pierson RN Progress towards clinical xenotransplantation FRONTIERS IN BIOSCIENCE-LANDMARK. 2008 JAN 1; 13: 204-220	0	20	17	158
7220	7220 Rezzoug F, Huang YM, Tanner MK, Wysoczynski M, Schanie CL, et al. TNF-alpha is critical to facilitate hemopoietic stem cell engraftment and function JOURNAL OF IMMUNOLOGY. 2008 JAN 1; 180 (1): 49-57	1	16	4	47
#	Date / Author / Journal	LCS	GCS	LCR	CR
7221	7221 Lengagne R, Graff-Dubois S, Garcette M, Renia L, Kato M, et al. Distinct role for CD8 T cells toward cutaneous tumors and visceral metastases JOURNAL OF IMMUNOLOGY. 2008 JAN 1; 180 (1): 130-137	0	12	0	47
7222	7222 Pasquali L, Giannoukakis N, Trucco M Induction of immune tolerance to facilitate beta cell regeneration in type 1 diabetes ADVANCED DRUG DELIVERY REVIEWS. 2008 JAN 14; 60 (2): 106-113	0	7	6	83
7223	7223 Yagyu S, Morimoto A, Kakazu N, Tamura S, Fujiki A, et al. Late appearance of a Philadelphia chromosome in a patient with therapy-related acute myeloid leukemia and high expression of EVI1 CANCER GENETICS AND CYTOGENETICS. 2008 JAN 15; 180 (2): 115-120	0	3	1	19
7224	7224 Guo K, Inaba M, Li M, An J, Cui W, et al. Long-term donor-specific tolerance in rat cardiac allografts by intrabone marrow injection of donor bone marrow cells TRANSPLANTATION. 2008 JAN 15; 85 (1): 93-101	2	10	22	37
7225	7225 Nestvold JM, Omdal BK, Dai KZ, Martens A, Benestad HB, et al. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease TRANSPLANTATION. 2008 JAN 15; 85 (1): 102-111	3	6	16	43
7226	7226 Murata H, Ratajczak P, Meignin V, Groussard O, Fournier M, et al. Endothelial cell chimerism associated with graft rejection after human lung transplantation TRANSPLANTATION. 2008 JAN 15; 85 (1): 150-154	2	3	12	27
7227	7227 Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, et al. Brief report: HLA-mismatched renal transplantation without maintenance immunosuppression NEW ENGLAND JOURNAL OF MEDICINE. 2008 JAN 24; 358 (4): 353-361	114	306	16	28
7228	7228 Scandling JD, Busque S, Dejbakhsh-Jones S, Benike C, Millan MT, et al. Brief report: Tolerance and chimerism after renal and hematopoietic-cell transplantation NEW ENGLAND JOURNAL OF MEDICINE. 2008 JAN 24; 358 (4): 362-368	70	156	8	19
7229	7229 Alexander SI, Smith N, Hu M, Verran D, Shun A, et al. Brief report: Chimerism and tolerance in a recipient of a deceased-donor liver transplant NEW ENGLAND JOURNAL OF MEDICINE. 2008 JAN 24; 358 (4): 369-374	28	61	14	24
7230	7230 Starzl TE Immunosuppressive therapy and tolerance of organ allografts NEW ENGLAND JOURNAL OF MEDICINE. 2008 JAN 24; 358 (4): 407-411	12	26	11	14
#	Date / Author / Journal	LCS	GCS	LCR	CR
7231	7231 Lerch MM, Kohler G, Mayerle J, Hlouschek V, Senninger N, et al. Hepatocyte microchimerism in human liver transplant after stem cell mobilization AMERICAN JOURNAL OF GASTROENTEROLOGY. 2008 FEB; 103 (2): 496-498	0	0	4	15
7232	7232 Bacher U, Badbaran A, Fehse B, Zabelina T, Zander AR, et al. Detection of relapse following allogeneic stem cell transplantation in AML: NPM1-mutations precede the FLT3-LM/ITD and changes in chimerism ANNALS OF HEMATOLOGY. 2008 FEB; 87: S4-S4	0	0	0	0
7233	7233 Tiblad E, Westgren M Fetal stem-cell transplantation BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY. 2008 FEB; 22 (1): 189-201	0	3	29	79
7234	7234 Shatry AM, Levy RB PRE-TRANSPLANT INFUSION OF NATURALLY OCCURRING DONOR CD4+CD25+T CELLS SUPPORTS DONOR CHIMERISM IN MHC-MATCHED ALLOGENEIC HCT BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2008 FEB; 14 (2): 8-9	0	0	0	0
7235	7235 Ozyurek E, Cowan M, Koerper M, Baxter-Lowe LA, Horn B FLUCTUATIONS IN CD3+SUBSET CHIMERISM ARE NOT PREDICTIVE OF GRAFT REJECTION IN CHILDREN UNDERGOING TRANSPLANT FOR NOW MALIGNANT DISORDERS BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2008 FEB; 14 (2): 76-77	0	0	0	0
7236	7236 Bhatia M, Baldinger L, Billote G, Morris E, Bradley MB, et al. PRELIMINARY RESULTS OF NON-ABLATIVE CONDITIONING (NAC) WITH BUSULFAN (Bu), FLUDARABINE (Flu) AND ALEMTUZUMAB FOLLOWED BY ALLOGENEIC STEM CELL TRANSPLANTATION (AlloSCT) TO INDUCE MIXED DONOR CHIMERISM IN PATIENTS WITH SICKLE CELL DISEASE (SCD) BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2008 FEB; 14 (2): 82-83	1	1	0	0
7237	7237 Schneiderman J, Rademaker AW, Chaudry S, Tse W, Jacobson DA, et al. DONOR CHIMERISM KINETICS IN PEDIATRIC PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING (RIC) WITH ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2008 FEB; 14 (2): 83-83	0	0	0	0
7238	7238 Shimoni A, Shem-Tov N, Rand A, Rihakovsy E, Yerushahni R, et al. TREATMENT OF DONOR GRAFT FAILURE WITH AUTOLOGOUS OR ALLOGENEIC STEM CELL BOOST OR A SECOND ALLOGENEIC TRANSPLANT BASED ON CHIMERISM TESTING BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2008 FEB; 14 (2): 95-96	0	0	0	0
7239	7239 Dean RM, Sobecks R, Rybicki L, Brown S, Copelan E, et al. PREDICTORS AND IMPACT OF DONOR T-CELL CHIMERISM IN MYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2008 FEB; 14 (2): 109-109	0	0	0	0
7240	7240 O'Donnell PV, Woolfrey AE, Storer B, Sorror ML, Furlong T, et al. EFFECT OF SUBSTITUTING FLUDARABINE AND THYMOGLOBULIN FOR CYCLOPHOSPHAMIDE IN BUSULFAN-BASED CONDITIONING REGIMENS ON T-CELL CHIMERISM AND OUTCOMES AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2008 FEB; 14 (2): 112-113	0	2	0	0
#	Date / Author / Journal	LCS	GCS	LCR	CR
7241	7241 Uzunel M, Mattsson J, Hauzenberger D, Ringden O MINIMAL RESIDUAL DISEASE AND CHIMERISM IN CML PATIENTS RECEIVING ALLOGENEIC TRANSPLANTS AFTER MYELOABLATIVE OR REDUCED CONDITIONING BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2008 FEB; 14 (2): 144-144	0	0	0	0
7242	7242 Laport GG, Sandmaier BM, Storer BE, Scott BL, Stuart MJ, et al. Reduced-intensity conditioning follow by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2008 FEB; 14 (2): 246-255	2	48	8	35
7243	7243 Hansen MD, Filipovich AH, Davies SM, Mehta P, Bleesing J, et al. Allogeneic hematopoietic cell transplantation (HCT) in Hurler's syndrome using a reduced intensity preparative regimen BONE MARROW TRANSPLANTATION. 2008 FEB; 41 (4): 349-353	0	2	6	34
7244	7244 Perez A, Gonzalez-Vicent M, Ramirez M, Sevilla J, Madero L, et al. Intentional induction of mixed haematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic stem cell transplantation in childhood leukaemia patients BRITISH JOURNAL OF HAEMATOLOGY. 2008 FEB; 140 (3): 340-343	1	1	6	14
7245	7245 Boettcher C, Ulbricht E, Helmlinger D, Mack AF, Reichenbach A, et al. Long-term engraftment of systemically transplanted, gene-modified bone marrow-derived cells in the adult mouse retina BRITISH JOURNAL OF OPHTHALMOLOGY. 2008 FEB; 92 (2): 272-275	0	1	3	26
7246	7246 Lysy PA, Campard D, Smets F, Malaise J, Mourad M, et al. Persistence of a chimerical phenotype after hepatocyte differentiation of human bone marrow mesenchymal stem cells CELL PROLIFERATION. 2008 FEB; 41 (1): 36-58	0	19	2	48
7247	7247 Tanaka K, Sata M, Natori T, Kim-Kaneyama J, Nose K, et al. Circulating progenitor cells contribute to neointimal formation in nonirradiated chimeric mice FASEB JOURNAL. 2008 FEB; 22 (2): 428-436	0	25	4	53
7248	7248 Mizoguchi E, Hachiya Y, Kawada M, Nagatani K, Ogawa A, et al. TNF receptor type I-dependent activation of innate responses to reduce intestinal damage-associated mortality GASTROENTEROLOGY. 2008 FEB; 134 (2): 470-480	0	16	0	34
7249	7249 Di Bonzo LV, Ferrero I, Cravanzola C, Mareschi K, Rustichell D, et al. Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential GUT. 2008 FEB; 57 (2): 223-231	0	69	8	49
7250	7250 Anderlini P, Saliba R, Acholonu S, Giralt SA, Andersson B, et al. Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 2008 FEB; 93 (2): 257-264	3	37	9	37
#	Date / Author / Journal	LCS	GCS	LCR	CR
7251	7251 Conrad R, Remberger M, Cederlund K, Ringden O, Barkholt L A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 2008 FEB; 93 (2): 265-272	1	3	15	45
7252	7252 Utoh R, Tateno C, Yamasaki C, Hiraga N, Kataoka M, et al. Susceptibility of chimeric mice with livers repopulated by serially subcultured human hepatocytes to hepatitis B virus HEPATOLOGY. 2008 FEB; 47 (2): 435-446	1	8	3	37
7253	7253 Toubai T, Hirate D, Shono Y, Ota S, Ibata M, et al. Chimerism and T-cell receptor repertoire analysis after unrelated cord blood transplantation with a reduced-intensity conditioning regimen following autologous stem cell transplantation for multiple myeloma INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 2008 FEB; 30 (1): 75-81	0	1	9	29
7254	7254 Slatter MA, Brigham K, Dickinson AM, Harvey HL, Barge D, et al. Long-term immune reconstitution after anti-CD52-treated or anti-CD34-treated hematopoietic stem cell transplantation for severe T-lymphocyte immunodeficiency JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2008 FEB; 121 (2): 361-367	4	20	7	27
7255	7255 Ng CY, Weiss MJ, Boskovic S, Kawai T, Millington TM, et al. Induction of mixed chimerism and transplantation tolerance in a non-human primate lung allograft model: Early results JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2008 FEB; 27 (2): S192-S192	0	0	0	0
7256	7256 Mewhort HE, Tao K, Maier SJ, Brown JM, West LJ Neonatally-induced cardiac Allograft acceptance: Assessment of microchimerism JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2008 FEB; 27 (2): S192-S193	0	0	0	0
7257	7257 Petrovan RJ, Yuan Y, Curtiss LK Expression of the Lyst(beige) mutation is atheroprotective in chow-fed apolipoprotein E-deficient mice JOURNAL OF LIPID RESEARCH. 2008 FEB; 49 (2): 429-437	0	0	0	27
7258	7258 Kumagai K, Vasanji A, Drazba JA, Butler RS, Muschler GF Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model JOURNAL OF ORTHOPAEDIC RESEARCH. 2008 FEB; 26 (2): 165-175	0	39	4	24
7259	7259 Dunne JR, Lee TH, Burns C, Cardo LJ, Curry K, et al. Transfusion-associated microchimerism in combat casualties JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE. 2008 FEB; 64 (2): S92-S97	0	7	12	44
7260	7260 Tsiodras S, Samonis G, Boumpas DT, Kontoyiannis DP Fungal infections complicating tumor necrosis factor alpha blockade therapy MAYO CLINIC PROCEEDINGS. 2008 FEB; 83 (2): 181-194	0	82	3	215
#	Date / Author / Journal	LCS	GCS	LCR	CR
7261	7261 Park TS, Kim MA, Lim JM, Han JY Production of quail (Coturnix japonica) germline chimeras derived from in vitro-cultured gonadal primordial germ cells MOLECULAR REPRODUCTION AND DEVELOPMENT. 2008 FEB; 75 (2): 274-281	2	12	3	17
7262	7262 Carletti B, Rossi F Neurogenesis in the cerebellum NEUROSCIENTIST. 2008 FEB; 14 (1): 91-100	0	45	6	79
7263	7263 Tomiyama K, Murase N, Stolz DB, Toyokawa H, O'Donnell DR, et al. Characterization of transplanted green fluorescent protein(+) bone marrow cells into adipose tissue STEM CELLS. 2008 FEB; 26 (2): 330-338	0	11	7	46
7264	7264 Verda L, Kim DA, Ikehara S, Statkute L, Bronesky D, et al. Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice STEM CELLS. 2008 FEB; 26 (2): 381-386	7	18	7	23
7265	7265 Bababeygy SR, Cheshier SH, Hou LC, Higgins DMO, Weissman IL, et al. Hematopoietic stem cell-derived pericytic cells in brain tumor angio-architecture STEM CELLS AND DEVELOPMENT. 2008 FEB; 17 (1): 11-18	0	21	2	28
7266	7266 Ha W, Yang W, Lei A, Gao Z, Yang C, et al. A caprine chimera produced by injection of embryonic germ cells into a blastocyst THERIOGENOLOGY. 2008 FEB; 69 (3): 340-348	0	0	7	32
7267	7267 de Moraes LV, Bueno V, Marguti I, Martins GA, Vallochi AL, et al. Donor bone marrow cells play a role in the prevention of accelerated graft rejection induced by semi-allogeneic spleen cells in transplantation TRANSPLANT IMMUNOLOGY. 2008 FEB; 18 (4): 330-337	0	0	21	44
7268	7268 Miyamoto N, Ishida H, Furusawa M, Shirnzu T, Shirakawa H, et al. Immunological status in three patients, thirty years after living related renal transplantation antibody production in long-term survivors TRANSPLANT IMMUNOLOGY. 2008 FEB; 18 (4): 368-372	0	2	2	15
7269	7269 Horner BM, Randolph MA, Huang CA, Butler PEM Skin tolerance: in search of the Holy Grail TRANSPLANT INTERNATIONAL. 2008 FEB; 21 (2): 101-112	2	8	47	124
7270	7270 Sykes M 2007 IXA Presidential Address. Progress toward an ideal source animal: opportunities and challenges in a changing world XENOTRANSPLANTATION. 2008 FEB; 15 (1): 7-13	0	2	13	62
#	Date / Author / Journal	LCS	GCS	LCR	CR
7271	7271 Archambeault S, Flores NJ, Yoshimi A, Kratz CP, Reising M, et al. Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia BLOOD. 2008 FEB 1; 111 (3): 1124-1127	1	13	1	15
7272	7272 Yang J, Popoola J, Khandwala S, Vadivel N, Vanguri V, et al. Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy CIRCULATION. 2008 FEB 5; 117 (5): 660-669	1	25	2	41
7273	7273 Doki T, Mello M, Mock D, Evans JM, Kearns-Jonker M Intragraft gene expression profile associated with the induction of tolerance BMC IMMUNOLOGY. 2008 FEB 11; 9: Art. No. 5	0	4	4	48
7274	7274 Guo ZY, He XS, Wu LW, Zhu XF, Ju WQ, et al. Graft-verse-host disease after liver transplantation: A report of two cases and review of literature WORLD JOURNAL OF GASTROENTEROLOGY. 2008 FEB 14; 14 (6): 974-979	2	5	6	13
7275	7275 Miyata E, Masuya M, Yoshida S, Nakamura S, Kato K, et al. Hematopoietic origin of hepatic stellate cells in the adult liver BLOOD. 2008 FEB 15; 111 (4): 2427-2435	2	32	9	64
7276	7276 Yamazaki A, Kawabata R, Shiomi K, Tsuchimoto J, Kiyomoto M, et al. Kruppel-like is required for nonskeletogenic mesoderm specification in the sea urchin embryo DEVELOPMENTAL BIOLOGY. 2008 FEB 15; 314 (2): 433-442	0	2	0	27
7277	7277 Sato E, Shick HE, Ransohoff RM, Hirose K Repopulation of cochlear macrophages in murine hematopoietic progenitor cell chimeras: The role of CX3CR1 JOURNAL OF COMPARATIVE NEUROLOGY. 2008 FEB 20; 506 (6): 930-942	4	7	0	25
7278	7278 Liu YP, Li ZQ, Nador RG, Strober S Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: Role of natural killer T cells TRANSPLANTATION. 2008 FEB 27; 85 (4): 607-614	3	6	15	32
7279	7279 Jonsson AM, Uzunel M, Gotherstrom C, Papadogiannakis N, Westgren M Maternal microchimerism in human fetal tissues AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2008 MAR; 198 (3): Art. No. 325.e1	0	0	12	37
7280	7280 Stoelting S, Heinze G, Nadrowitz R, Wagner T, Peters SO Bone marrow-derived endothelial cells contribute to angiogenesis in murine WEHI and JC tumors ANTICANCER RESEARCH. 2008 MAR-APR; 28 (2A): 771-777	0	1	1	19
#	Date / Author / Journal	LCS	GCS	LCR	CR
7281	7281 Lucarelli G, Gaziev J Advances in the allogeneic transplantation for thalassemia BLOOD REVIEWS. 2008 MAR; 22 (2): 53-63	12	44	7	67
7282	7282 Shimoni A, Shem-Tov N, Rand A, Ribakovsky E, Yerushalmi R, et al. Treatment of donor graft failure with autologous or allogeneic stem cell boost or a second allogeneic transplantation based on chimerism testing BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S10-S10	0	0	0	0
7283	7283 Verholen F, Levrat E, Passweg JR, Roosnek E, Helg C, et al. High proportion of mixed chimerism with T-cell depleted peripheral stem cell transplants followed by T-cell add-back in patients with aplastic anaemia BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S19-S20	0	0	0	0
7284	7284 Schneiker K, Schmitt T, Konur A, Hemmerling J, Bender K, et al. Langerhans cell chimerism early after T-cell depleted allogeneic haematopoietic stem cell transplantation BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S62-S62	0	0	0	0
7285	7285 Rupa J, Lewandowski K, Sawinski K, Nowak W, Kramer L, et al. Graft rejection and kinetics of lineage-specific chimerism in adult patients undergoing stem cell transplantation BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S86-S86	0	0	0	0
7286	7286 Mollet I, Revez D, Martin C, Plesa C, Giannoli C, et al. Follow-up of chimerism in myeloid cell fraction after allogeneic haematopoietic stem cell transplantation (HSCT) for patients with acute myeloid leukaemia BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S106-S107	0	0	0	0
7287	7287 Nonn M, Horz M, Khan SA, Shultz L, Handgretinger R, et al. Evaluation of engraftment and graft-versus-host reactivity of ex vivo modified human donor T-cell grafts in a chimeric NOD/SCID/IL2Rgcnull transplantation model BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S120-S120	0	0	0	0
7288	7288 Mueller S, Lange S, Altmann S, Weirich V, Vogel H, et al. Kinetics of Langerhans cell chimerism in the skin of dogs following 2Gy TBI allogeneic haematopoietic stem cell transplantation BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S123-S124	0	0	0	0
7289	7289 Shiber I, Hirshfeld E, Weiss L, Kasir J, Shapira Y The induction of bi-parental mixed chimerism in a murine model does not increase graft-versus-host disease despite T-cell repletion BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S126-S126	1	1	0	0
7290	7290 Marijt W, Baas I, von dem Borne P, Barge R, Deutz P, et al. Prevention of relapse by donor lymphocyte infusion for mixed chimerism 7 months after T-cell depleted allogeneic stem cell transplantation BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S161-S161	0	0	0	0
#	Date / Author / Journal	LCS	GCS	LCR	CR
7291	7291 Borne PAVD, Starrenburg CW, Marijt EW, Halkes CW, Falkenburg JH, et al. Donor lymphocyte infusion after reduced-intensity T-cell depleted stem cell transplantation induces conversion to full donor chimerism in most patients combined with graft-versus tumour responses and limited graft-versus-host disease BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S168-S169	0	0	0	0
7292	7292 Svenberg P, Mattsson J, Ringden O, Uzunel M Chimerism after allogeneic stem cell transplantation in patients with non-malignant disorders BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S175-S175	0	0	0	0
7293	7293 Nikolousis E, Craddock C, Tauro S, Mahendra P, McMullan D, et al. Pre-transplant characteristics can predict full donor chimerism at day 90 as well as disease-free survival and overall survival in reduced intensity Campath conditioning allografts BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S206-S207	0	0	0	0
7294	7294 Manzano C, Barroso D, Balsalobre P, Serrano D, Gomez-Pineda A, et al. Donor/recipient matching for short tandem repeat D3S1358 predicts severe acute GvHD in a chimerism mediated fashion after HLA-identical allogeneic stem cell transplantation BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S234-S235	0	0	0	0
7295	7295 Rupa J, Lewandowski K, Nowak W, Sawinski K, Czyz A, et al. T-lymphocytes CD3+ chimerism correlates with the incidence of graft-versus-host disease in patients undergoing allogeneic stem cell transplantation BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S238-S238	0	0	0	0
7296	7296 Di Martino D, Terranova MP, Di Duca M, Faraci M, Dallorso S, et al. Quantitative analysis of chimerism after allogeneic stem cell transplantation with non-myeloablative conditioning in paediatric patients BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S302-S303	0	0	0	0
7297	7297 Stein J, Kristt D, Klein T, Kodman Y, Yaniv I Lineage specific chimerism analysis using immunomagnetic cell separation in children following haematopoietic stem cell transplantation BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S304-S304	0	0	0	0
7298	7298 Blau O, Gentilini C, Nogai A, Reinwald M, Sindram A, et al. Molecular-genetic monitoring of haematopoietic chimerism and minimal residual disease in AML patients after stem cell transplantation BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S334-S335	0	0	0	0
7299	7299 Bacher U, Badbaran A, Fehse B, Zabelina T, Lehmann F, et al. Quantitative monitoring of NPM1 mutations versus chimerism for detection of impending relapse after allogeneic stem cell transplantation in AML BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S335-S335	0	0	0	0
7300	7300 Uzunel M, Mattsson J, Hauzenberger D, Ringden O Minimal residual disease and chimerism in CML patients receiving allogeneic transplants after myeloablative or reduced-intensity conditioning BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S335-S336	0	0	0	0

Date / Author / Journal

LCS

GCS

LCR

2008

7201

7201 Bethge WA, Faul C, Bornhauster M, Stuhler G, Beelen DW, et al.

Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: An update

BLOOD CELLS MOLECULES AND DISEASES. 2008 JAN-FEB; 40 (1): 13-19

7202

7202 Lang P, Mueller I, Greil J, Bader P, Schumm M, et al.

Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients

BLOOD CELLS MOLECULES AND DISEASES. 2008 JAN-FEB; 40 (1): 33-39

7203

7203 Strober S

Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation

BLOOD CELLS MOLECULES AND DISEASES. 2008 JAN-FEB; 40 (1): 48-54

7204

7204 van Rood J, Oudshoorn M

Eleven million donors in Bone Marrow Donors Worldwide! Time for reassessment?

BONE MARROW TRANSPLANTATION. 2008 JAN; 41 (1): 1-9

7205

7205 Bhatia M, Walters MC

Hematopoietic cell transplantation for thalassemia and sickle cell disease: past, present and future

BONE MARROW TRANSPLANTATION. 2008 JAN; 41 (2): 109-117

7206

7206 Grinnemo KH, Sylven C, Hovatta O, Dellgren G, Corbascio M

Immunogenicity of human embryonic stem cells

CELL AND TISSUE RESEARCH. 2008 JAN; 331 (1): 67-78

7207

7207 Chen DP, Tsai SH, Tseng CP, Wu TL, Chang PY, et al.

Bone marrow transplant relapse with loss of an allele

CLINICA CHIMICA ACTA. 2008 JAN; 387 (1-2): 161-164

7208

7208 Gleicher N

Missed immunological opportunities in pregnancy

EXPERT REVIEW OF CLINICAL IMMUNOLOGY. 2008 JAN; 4 (1): 1-3

7209

7209 Bohne F, Chmielewski M, Ebert G, Wiegmann K, Kurschner T, et al.

T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes

GASTROENTEROLOGY. 2008 JAN; 134 (1): 239-247

7210

7210 Mints M, Jansson M, Sadeghi B, Westgren M, Uzunel M, et al.

Endometrial endothelial cells are derived from donor stem cells in a bone marrow transplant recipient

HUMAN REPRODUCTION. 2008 JAN; 23 (1): 139-143

Date / Author / Journal

LCS

GCS

LCR

7211

7211 Hasegawa D, Fukushima M, Hosokawa Y, Takeda H, Kawasaki K, et al.

Successful treatment of chronic granulomatous disease with fludarabine-based reduced-intensity conditioning and unrelated bone marrow transplantation

INTERNATIONAL JOURNAL OF HEMATOLOGY. 2008 JAN; 87 (1): 88-90

7212

7212 Boban I, Barisic-Dujmovic T, Clark SH

Parabiosis and transplantation models show no evidence of circulating dermal fibroblast progenitors in bleomycin-induced skin fibrosis

JOURNAL OF CELLULAR PHYSIOLOGY. 2008 JAN; 214 (1): 230-237

7213

7213 Birnbaum F, Jehle T, Schwartzkopff J, Sokolovska Y, Bohringer D, et al.

Basiliximab following penetrating risk-keratoplasty - A prospective randomized pilot study

KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE. 2008 JAN; 225 (1): 62-65

7214

7214 Joffre O, Santolaria T, Calise D, Al Saati T, Hudrisier D, et al.

Prevention of acute and chronic allograft rejection with CD4(+)CD25(+)Foxp3(+) regulatory T lymphocytes

NATURE MEDICINE. 2008 JAN; 14 (1): 88-92

142

7215

7215 Siebolts U, Thiele J, Zander T, Ditschkowski M, Beelen DW, et al.

Differences in proportion and dynamics of recipient hematopoiesis following hematopoietic cell transplantation in CML and IMF

ONCOLOGY REPORTS. 2008 JAN; 19 (1): 287-292

7216

7216 Reinhard H, Klingebiel T, Lang P, Bader P, Niethammer D, et al.

Stem cell transplantation for polycythemia vera

PEDIATRIC BLOOD & CANCER. 2008 JAN; 50 (1): 124-126

7217

7217 Koch U, Wilson A, Cobas M, Kemler R, MacDonald HR, et al.

Simultaneous loss of beta- and gamma-catenin does not perturb hematopoiesis or lymphopoiesis

BLOOD. 2008 JAN 1; 111 (1): 160-164

7218

7218 Ozsahin H, Cavazzana-Calvo M, Notarangelo LD, Schulz A, Thrasher AJ, et al.

Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation

BLOOD. 2008 JAN 1; 111 (1): 439-445

7219

7219 Schuurman HJ, Pierson RN

Progress towards clinical xenotransplantation

FRONTIERS IN BIOSCIENCE-LANDMARK. 2008 JAN 1; 13: 204-220

158

7220

7220 Rezzoug F, Huang YM, Tanner MK, Wysoczynski M, Schanie CL, et al.

TNF-alpha is critical to facilitate hemopoietic stem cell engraftment and function

JOURNAL OF IMMUNOLOGY. 2008 JAN 1; 180 (1): 49-57

Date / Author / Journal

LCS

GCS

LCR

7221

7221 Lengagne R, Graff-Dubois S, Garcette M, Renia L, Kato M, et al.

Distinct role for CD8 T cells toward cutaneous tumors and visceral metastases

JOURNAL OF IMMUNOLOGY. 2008 JAN 1; 180 (1): 130-137

7222

7222 Pasquali L, Giannoukakis N, Trucco M

Induction of immune tolerance to facilitate beta cell regeneration in type 1 diabetes

ADVANCED DRUG DELIVERY REVIEWS. 2008 JAN 14; 60 (2): 106-113

7223

7223 Yagyu S, Morimoto A, Kakazu N, Tamura S, Fujiki A, et al.

Late appearance of a Philadelphia chromosome in a patient with therapy-related acute myeloid leukemia and high expression of EVI1

CANCER GENETICS AND CYTOGENETICS. 2008 JAN 15; 180 (2): 115-120

7224

7224 Guo K, Inaba M, Li M, An J, Cui W, et al.

Long-term donor-specific tolerance in rat cardiac allografts by intrabone marrow injection of donor bone marrow cells

TRANSPLANTATION. 2008 JAN 15; 85 (1): 93-101

7225

7225 Nestvold JM, Omdal BK, Dai KZ, Martens A, Benestad HB, et al.

A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease

TRANSPLANTATION. 2008 JAN 15; 85 (1): 102-111

7226

7226 Murata H, Ratajczak P, Meignin V, Groussard O, Fournier M, et al.

Endothelial cell chimerism associated with graft rejection after human lung transplantation

TRANSPLANTATION. 2008 JAN 15; 85 (1): 150-154

7227

7227 Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, et al.

Brief report: HLA-mismatched renal transplantation without maintenance immunosuppression

NEW ENGLAND JOURNAL OF MEDICINE. 2008 JAN 24; 358 (4): 353-361

114

306

7228

7228 Scandling JD, Busque S, Dejbakhsh-Jones S, Benike C, Millan MT, et al.

Brief report: Tolerance and chimerism after renal and hematopoietic-cell transplantation

NEW ENGLAND JOURNAL OF MEDICINE. 2008 JAN 24; 358 (4): 362-368

156

7229

7229 Alexander SI, Smith N, Hu M, Verran D, Shun A, et al.

Brief report: Chimerism and tolerance in a recipient of a deceased-donor liver transplant

NEW ENGLAND JOURNAL OF MEDICINE. 2008 JAN 24; 358 (4): 369-374

7230

7230 Starzl TE

Immunosuppressive therapy and tolerance of organ allografts

NEW ENGLAND JOURNAL OF MEDICINE. 2008 JAN 24; 358 (4): 407-411

Date / Author / Journal

LCS

GCS

LCR

7231

7231 Lerch MM, Kohler G, Mayerle J, Hlouschek V, Senninger N, et al.

Hepatocyte microchimerism in human liver transplant after stem cell mobilization

AMERICAN JOURNAL OF GASTROENTEROLOGY. 2008 FEB; 103 (2): 496-498

7232

7232 Bacher U, Badbaran A, Fehse B, Zabelina T, Zander AR, et al.

Detection of relapse following allogeneic stem cell transplantation in AML: NPM1-mutations precede the FLT3-LM/ITD and changes in chimerism

ANNALS OF HEMATOLOGY. 2008 FEB; 87: S4-S4

7233

7233 Tiblad E, Westgren M

Fetal stem-cell transplantation

BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY. 2008 FEB; 22 (1): 189-201

7234

7234 Shatry AM, Levy RB

PRE-TRANSPLANT INFUSION OF NATURALLY OCCURRING DONOR CD4+CD25+T CELLS SUPPORTS DONOR CHIMERISM IN MHC-MATCHED ALLOGENEIC HCT

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2008 FEB; 14 (2): 8-9

7235

7235 Ozyurek E, Cowan M, Koerper M, Baxter-Lowe LA, Horn B

FLUCTUATIONS IN CD3+SUBSET CHIMERISM ARE NOT PREDICTIVE OF GRAFT REJECTION IN CHILDREN UNDERGOING TRANSPLANT FOR NOW MALIGNANT DISORDERS

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2008 FEB; 14 (2): 76-77

7236

7236 Bhatia M, Baldinger L, Billote G, Morris E, Bradley MB, et al.

PRELIMINARY RESULTS OF NON-ABLATIVE CONDITIONING (NAC) WITH BUSULFAN (Bu), FLUDARABINE (Flu) AND ALEMTUZUMAB FOLLOWED BY ALLOGENEIC STEM CELL TRANSPLANTATION (AlloSCT) TO INDUCE MIXED DONOR CHIMERISM IN PATIENTS WITH SICKLE CELL DISEASE (SCD)

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2008 FEB; 14 (2): 82-83

7237

7237 Schneiderman J, Rademaker AW, Chaudry S, Tse W, Jacobson DA, et al.

DONOR CHIMERISM KINETICS IN PEDIATRIC PATIENTS UNDERGOING REDUCED INTENSITY CONDITIONING (RIC) WITH ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2008 FEB; 14 (2): 83-83

7238

7238 Shimoni A, Shem-Tov N, Rand A, Rihakovsy E, Yerushahni R, et al.

TREATMENT OF DONOR GRAFT FAILURE WITH AUTOLOGOUS OR ALLOGENEIC STEM CELL BOOST OR A SECOND ALLOGENEIC TRANSPLANT BASED ON CHIMERISM TESTING

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2008 FEB; 14 (2): 95-96

7239

7239 Dean RM, Sobecks R, Rybicki L, Brown S, Copelan E, et al.

PREDICTORS AND IMPACT OF DONOR T-CELL CHIMERISM IN MYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2008 FEB; 14 (2): 109-109

7240

7240 O'Donnell PV, Woolfrey AE, Storer B, Sorror ML, Furlong T, et al.

EFFECT OF SUBSTITUTING FLUDARABINE AND THYMOGLOBULIN FOR CYCLOPHOSPHAMIDE IN BUSULFAN-BASED CONDITIONING REGIMENS ON T-CELL CHIMERISM AND OUTCOMES AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT)

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2008 FEB; 14 (2): 112-113

Date / Author / Journal

LCS

GCS

LCR

7241

7241 Uzunel M, Mattsson J, Hauzenberger D, Ringden O

MINIMAL RESIDUAL DISEASE AND CHIMERISM IN CML PATIENTS RECEIVING ALLOGENEIC TRANSPLANTS AFTER MYELOABLATIVE OR REDUCED CONDITIONING

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2008 FEB; 14 (2): 144-144

7242

7242 Laport GG, Sandmaier BM, Storer BE, Scott BL, Stuart MJ, et al.

Reduced-intensity conditioning follow by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2008 FEB; 14 (2): 246-255

7243

7243 Hansen MD, Filipovich AH, Davies SM, Mehta P, Bleesing J, et al.

Allogeneic hematopoietic cell transplantation (HCT) in Hurler's syndrome using a reduced intensity preparative regimen

BONE MARROW TRANSPLANTATION. 2008 FEB; 41 (4): 349-353

7244

7244 Perez A, Gonzalez-Vicent M, Ramirez M, Sevilla J, Madero L, et al.

Intentional induction of mixed haematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic stem cell transplantation in childhood leukaemia patients

BRITISH JOURNAL OF HAEMATOLOGY. 2008 FEB; 140 (3): 340-343

7245

7245 Boettcher C, Ulbricht E, Helmlinger D, Mack AF, Reichenbach A, et al.

Long-term engraftment of systemically transplanted, gene-modified bone marrow-derived cells in the adult mouse retina

BRITISH JOURNAL OF OPHTHALMOLOGY. 2008 FEB; 92 (2): 272-275

7246

7246 Lysy PA, Campard D, Smets F, Malaise J, Mourad M, et al.

Persistence of a chimerical phenotype after hepatocyte differentiation of human bone marrow mesenchymal stem cells

CELL PROLIFERATION. 2008 FEB; 41 (1): 36-58

7247

7247 Tanaka K, Sata M, Natori T, Kim-Kaneyama J, Nose K, et al.

Circulating progenitor cells contribute to neointimal formation in nonirradiated chimeric mice

FASEB JOURNAL. 2008 FEB; 22 (2): 428-436

7248

7248 Mizoguchi E, Hachiya Y, Kawada M, Nagatani K, Ogawa A, et al.

TNF receptor type I-dependent activation of innate responses to reduce intestinal damage-associated mortality

GASTROENTEROLOGY. 2008 FEB; 134 (2): 470-480

7249

7249 Di Bonzo LV, Ferrero I, Cravanzola C, Mareschi K, Rustichell D, et al.

Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential

GUT. 2008 FEB; 57 (2): 223-231

7250

7250 Anderlini P, Saliba R, Acholonu S, Giralt SA, Andersson B, et al.

Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 2008 FEB; 93 (2): 257-264

Date / Author / Journal

LCS

GCS

LCR

7251

7251 Conrad R, Remberger M, Cederlund K, Ringden O, Barkholt L

A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 2008 FEB; 93 (2): 265-272

7252

7252 Utoh R, Tateno C, Yamasaki C, Hiraga N, Kataoka M, et al.

Susceptibility of chimeric mice with livers repopulated by serially subcultured human hepatocytes to hepatitis B virus

HEPATOLOGY. 2008 FEB; 47 (2): 435-446

7253

7253 Toubai T, Hirate D, Shono Y, Ota S, Ibata M, et al.

Chimerism and T-cell receptor repertoire analysis after unrelated cord blood transplantation with a reduced-intensity conditioning regimen following autologous stem cell transplantation for multiple myeloma

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY. 2008 FEB; 30 (1): 75-81

7254

7254 Slatter MA, Brigham K, Dickinson AM, Harvey HL, Barge D, et al.

Long-term immune reconstitution after anti-CD52-treated or anti-CD34-treated hematopoietic stem cell transplantation for severe T-lymphocyte immunodeficiency

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2008 FEB; 121 (2): 361-367

7255

7255 Ng CY, Weiss MJ, Boskovic S, Kawai T, Millington TM, et al.

Induction of mixed chimerism and transplantation tolerance in a non-human primate lung allograft model: Early results

JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2008 FEB; 27 (2): S192-S192

7256

7256 Mewhort HE, Tao K, Maier SJ, Brown JM, West LJ

Neonatally-induced cardiac Allograft acceptance: Assessment of microchimerism

JOURNAL OF HEART AND LUNG TRANSPLANTATION. 2008 FEB; 27 (2): S192-S193

7257

7257 Petrovan RJ, Yuan Y, Curtiss LK

Expression of the Lyst(beige) mutation is atheroprotective in chow-fed apolipoprotein E-deficient mice

JOURNAL OF LIPID RESEARCH. 2008 FEB; 49 (2): 429-437

7258

7258 Kumagai K, Vasanji A, Drazba JA, Butler RS, Muschler GF

Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model

JOURNAL OF ORTHOPAEDIC RESEARCH. 2008 FEB; 26 (2): 165-175

7259

7259 Dunne JR, Lee TH, Burns C, Cardo LJ, Curry K, et al.

Transfusion-associated microchimerism in combat casualties

JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE. 2008 FEB; 64 (2): S92-S97

7260

7260 Tsiodras S, Samonis G, Boumpas DT, Kontoyiannis DP

Fungal infections complicating tumor necrosis factor alpha blockade therapy

MAYO CLINIC PROCEEDINGS. 2008 FEB; 83 (2): 181-194

215

Date / Author / Journal

LCS

GCS

LCR

7261

7261 Park TS, Kim MA, Lim JM, Han JY

Production of quail (Coturnix japonica) germline chimeras derived from in vitro-cultured gonadal primordial germ cells

MOLECULAR REPRODUCTION AND DEVELOPMENT. 2008 FEB; 75 (2): 274-281

7262

7262 Carletti B, Rossi F

Neurogenesis in the cerebellum

NEUROSCIENTIST. 2008 FEB; 14 (1): 91-100

7263

7263 Tomiyama K, Murase N, Stolz DB, Toyokawa H, O'Donnell DR, et al.

Characterization of transplanted green fluorescent protein(+) bone marrow cells into adipose tissue

STEM CELLS. 2008 FEB; 26 (2): 330-338

7264

7264 Verda L, Kim DA, Ikehara S, Statkute L, Bronesky D, et al.

Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice

STEM CELLS. 2008 FEB; 26 (2): 381-386

7265

7265 Bababeygy SR, Cheshier SH, Hou LC, Higgins DMO, Weissman IL, et al.

Hematopoietic stem cell-derived pericytic cells in brain tumor angio-architecture

STEM CELLS AND DEVELOPMENT. 2008 FEB; 17 (1): 11-18

7266

7266 Ha W, Yang W, Lei A, Gao Z, Yang C, et al.

A caprine chimera produced by injection of embryonic germ cells into a blastocyst

THERIOGENOLOGY. 2008 FEB; 69 (3): 340-348

7267

7267 de Moraes LV, Bueno V, Marguti I, Martins GA, Vallochi AL, et al.

Donor bone marrow cells play a role in the prevention of accelerated graft rejection induced by semi-allogeneic spleen cells in transplantation

TRANSPLANT IMMUNOLOGY. 2008 FEB; 18 (4): 330-337

7268

7268 Miyamoto N, Ishida H, Furusawa M, Shirnzu T, Shirakawa H, et al.

Immunological status in three patients, thirty years after living related renal transplantation antibody production in long-term survivors

TRANSPLANT IMMUNOLOGY. 2008 FEB; 18 (4): 368-372

7269

7269 Horner BM, Randolph MA, Huang CA, Butler PEM

Skin tolerance: in search of the Holy Grail

TRANSPLANT INTERNATIONAL. 2008 FEB; 21 (2): 101-112

124

7270

7270 Sykes M

2007 IXA Presidential Address. Progress toward an ideal source animal: opportunities and challenges in a changing world

XENOTRANSPLANTATION. 2008 FEB; 15 (1): 7-13

Date / Author / Journal

LCS

GCS

LCR

7271

7271 Archambeault S, Flores NJ, Yoshimi A, Kratz CP, Reising M, et al.

Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia

BLOOD. 2008 FEB 1; 111 (3): 1124-1127

7272

7272 Yang J, Popoola J, Khandwala S, Vadivel N, Vanguri V, et al.

Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy

CIRCULATION. 2008 FEB 5; 117 (5): 660-669

7273

7273 Doki T, Mello M, Mock D, Evans JM, Kearns-Jonker M

Intragraft gene expression profile associated with the induction of tolerance

BMC IMMUNOLOGY. 2008 FEB 11; 9: Art. No. 5

7274

7274 Guo ZY, He XS, Wu LW, Zhu XF, Ju WQ, et al.

Graft-verse-host disease after liver transplantation: A report of two cases and review of literature

WORLD JOURNAL OF GASTROENTEROLOGY. 2008 FEB 14; 14 (6): 974-979

7275

7275 Miyata E, Masuya M, Yoshida S, Nakamura S, Kato K, et al.

Hematopoietic origin of hepatic stellate cells in the adult liver

BLOOD. 2008 FEB 15; 111 (4): 2427-2435

7276

7276 Yamazaki A, Kawabata R, Shiomi K, Tsuchimoto J, Kiyomoto M, et al.

Kruppel-like is required for nonskeletogenic mesoderm specification in the sea urchin embryo

DEVELOPMENTAL BIOLOGY. 2008 FEB 15; 314 (2): 433-442

7277

7277 Sato E, Shick HE, Ransohoff RM, Hirose K

Repopulation of cochlear macrophages in murine hematopoietic progenitor cell chimeras: The role of CX3CR1

JOURNAL OF COMPARATIVE NEUROLOGY. 2008 FEB 20; 506 (6): 930-942

7278

7278 Liu YP, Li ZQ, Nador RG, Strober S

Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: Role of natural killer T cells

TRANSPLANTATION. 2008 FEB 27; 85 (4): 607-614

7279

7279 Jonsson AM, Uzunel M, Gotherstrom C, Papadogiannakis N, Westgren M

Maternal microchimerism in human fetal tissues

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2008 MAR; 198 (3): Art. No. 325.e1

7280

7280 Stoelting S, Heinze G, Nadrowitz R, Wagner T, Peters SO

Bone marrow-derived endothelial cells contribute to angiogenesis in murine WEHI and JC tumors

ANTICANCER RESEARCH. 2008 MAR-APR; 28 (2A): 771-777

Date / Author / Journal

LCS

GCS

LCR

7281

7281 Lucarelli G, Gaziev J

Advances in the allogeneic transplantation for thalassemia

BLOOD REVIEWS. 2008 MAR; 22 (2): 53-63

7282

7282 Shimoni A, Shem-Tov N, Rand A, Ribakovsky E, Yerushalmi R, et al.

Treatment of donor graft failure with autologous or allogeneic stem cell boost or a second allogeneic transplantation based on chimerism testing

BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S10-S10

7283

7283 Verholen F, Levrat E, Passweg JR, Roosnek E, Helg C, et al.

High proportion of mixed chimerism with T-cell depleted peripheral stem cell transplants followed by T-cell add-back in patients with aplastic anaemia

BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S19-S20

7284

7284 Schneiker K, Schmitt T, Konur A, Hemmerling J, Bender K, et al.

Langerhans cell chimerism early after T-cell depleted allogeneic haematopoietic stem cell transplantation

BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S62-S62

7285

7285 Rupa J, Lewandowski K, Sawinski K, Nowak W, Kramer L, et al.

Graft rejection and kinetics of lineage-specific chimerism in adult patients undergoing stem cell transplantation

BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S86-S86

7286

7286 Mollet I, Revez D, Martin C, Plesa C, Giannoli C, et al.

Follow-up of chimerism in myeloid cell fraction after allogeneic haematopoietic stem cell transplantation (HSCT) for patients with acute myeloid leukaemia

BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S106-S107

7287

7287 Nonn M, Horz M, Khan SA, Shultz L, Handgretinger R, et al.

Evaluation of engraftment and graft-versus-host reactivity of ex vivo modified human donor T-cell grafts in a chimeric NOD/SCID/IL2Rgcnull transplantation model

BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S120-S120

7288

7288 Mueller S, Lange S, Altmann S, Weirich V, Vogel H, et al.

Kinetics of Langerhans cell chimerism in the skin of dogs following 2Gy TBI allogeneic haematopoietic stem cell transplantation

BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S123-S124

7289

7289 Shiber I, Hirshfeld E, Weiss L, Kasir J, Shapira Y

The induction of bi-parental mixed chimerism in a murine model does not increase graft-versus-host disease despite T-cell repletion

BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S126-S126

7290

7290 Marijt W, Baas I, von dem Borne P, Barge R, Deutz P, et al.

Prevention of relapse by donor lymphocyte infusion for mixed chimerism 7 months after T-cell depleted allogeneic stem cell transplantation

BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S161-S161

Date / Author / Journal

LCS

GCS

LCR

7291

7291 Borne PAVD, Starrenburg CW, Marijt EW, Halkes CW, Falkenburg JH, et al.

Donor lymphocyte infusion after reduced-intensity T-cell depleted stem cell transplantation induces conversion to full donor chimerism in most patients combined with graft-versus tumour responses and limited graft-versus-host disease

BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S168-S169

7292

7292 Svenberg P, Mattsson J, Ringden O, Uzunel M

Chimerism after allogeneic stem cell transplantation in patients with non-malignant disorders

BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S175-S175

7293

7293 Nikolousis E, Craddock C, Tauro S, Mahendra P, McMullan D, et al.

Pre-transplant characteristics can predict full donor chimerism at day 90 as well as disease-free survival and overall survival in reduced intensity Campath conditioning allografts

BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S206-S207

7294

7294 Manzano C, Barroso D, Balsalobre P, Serrano D, Gomez-Pineda A, et al.

Donor/recipient matching for short tandem repeat D3S1358 predicts severe acute GvHD in a chimerism mediated fashion after HLA-identical allogeneic stem cell transplantation

BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S234-S235

7295

7295 Rupa J, Lewandowski K, Nowak W, Sawinski K, Czyz A, et al.

T-lymphocytes CD3+ chimerism correlates with the incidence of graft-versus-host disease in patients undergoing allogeneic stem cell transplantation

BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S238-S238

7296

7296 Di Martino D, Terranova MP, Di Duca M, Faraci M, Dallorso S, et al.

Quantitative analysis of chimerism after allogeneic stem cell transplantation with non-myeloablative conditioning in paediatric patients

BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S302-S303

7297

7297 Stein J, Kristt D, Klein T, Kodman Y, Yaniv I

Lineage specific chimerism analysis using immunomagnetic cell separation in children following haematopoietic stem cell transplantation

BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S304-S304

7298

7298 Blau O, Gentilini C, Nogai A, Reinwald M, Sindram A, et al.

Molecular-genetic monitoring of haematopoietic chimerism and minimal residual disease in AML patients after stem cell transplantation

BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S334-S335

7299

7299 Bacher U, Badbaran A, Fehse B, Zabelina T, Lehmann F, et al.

Quantitative monitoring of NPM1 mutations versus chimerism for detection of impending relapse after allogeneic stem cell transplantation in AML

BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S335-S335

7300

7300 Uzunel M, Mattsson J, Hauzenberger D, Ringden O

Minimal residual disease and chimerism in CML patients receiving allogeneic transplants after myeloablative or reduced-intensity conditioning

BONE MARROW TRANSPLANTATION. 2008 MAR; 41: S335-S336

Chimerism and Transplantation topic search 8998 papers downloaded from Web of Science. Topic=((chimer* OR microchimer) AND (graft OR allograft* OR homograft* OR transplant*)) Timespan=1950-01-01 - 2011-12-31. Databases=SCI-EXPANDED, SSCI, A&HCI. Lemmatization=Off AND 85 papers added from the cited references list.	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 52148, GCS 386809, CR 295585 Collection span: 1945 - 2011
List of All Records